Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME   >  CORPORATE INFO >  COMPANY NEWS
Company News      
Cipla Ltd.
Change Company   
BSE Code 500087
ISIN Demat INE059A01026
Book Value 378.53
NSE Code CIPLA
Dividend Yield % 0.86
Market Cap 1220102.36
P/E 26.21
EPS 57.63
Face Value 2  
21-Apr-2025 Cipla’s arm’s Goa facility classified as VAI by U...
11-Apr-2025 Cipla gets USFDA’s final approval for generic can...
11-Apr-2025 Cipla informs about disclosure
11-Apr-2025 Cipla jumps on getting USFDA’s final approval for...
24-Feb-2025 Cipla rises on the bourses
21-Feb-2025 USFDA Inspection At Analytical Testing Facility ...
21-Feb-2025 Cipla gets USFDA’s final nod for Nilotinib Capsul...
21-Feb-2025 USFDA concludes cGMP inspection at analytical tes...
21-Feb-2025 Cipla declines on the BSE
18-Feb-2025 Cipla informs about presentation for analyst
11-Feb-2025 Cipla trades higher on the BSE
10-Feb-2025 USFDA classifies Cipla’s Bengaluru manufacturing ...
10-Feb-2025 Cipla falls as USFDA classifies its Bengaluru man...
03-Feb-2025 Cipla to invest in Cipla Medpro South Africa Prop...
28-Jan-2025 Cipla reports 47% rise in Q3 consolidated net pro...
Page 1 of 3
Prev || Next
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.